Rainer Lichtenberger, Ph.D. MBA
25 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 12 years CEO/COO experience in several SME, raised € 35 Mn venture funds.Read more
Christian Wallasch, Ph.D.
Seasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.Read more
Martin Bauer, M.D., FNWC
Board certified anesthetist with more than 15 years in industrial research and development. Senior management positions at Merck, Basilea, ICON, Otsuka in the past.Read more
Prof. Oliver Planz, Ph.D.
Universität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.Read more
Björn Cochlovius, Ph.D., Assoc. Prof.
VP Business Development
20 years leadership positions in SMEs (Head R&D Affitech, CEO OnTarget) and big pharma (Roche, Otsuka, Abbvie). Working experiences in Europe and Asia. Background in R&D, Business Development, M&A, FinancingRead more